|
|
Office Practice of Primary Care Medicine 2025 - LIVE STREAMING
The Comprehensive 2025 Update on Office-Based Primary Care Medicine
Taught Live Online by Harvard Medical School's Leading Clinical Faculty
Office Practice of Primary Care Medicine will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies.
OVERVIEW
Office Practice of Primary Care Medicine provides comprehensive reviews of the most important recent advances impacting primary care medicine and guidance to incorporate these chan... |
|
|
Comprehensive Sterile Compounding Certificate Program
May 8th - 10th, 2025
COMPREHENSIVE STERILE COMPOUNDING is an accredited 3-day, 20-hour (2.0 CEUs) practice-based course designed for pharmacists and technicians who are experienced in compounding.
Physicians and other healthcare professionals are welcome to attend. This course will also provide initial aseptic training for pharmacists and technicians required by their state board of pharmacy to compound sterile preparations.
Participants are instructed in the proper aseptic techniques... |
|
|
Pulmonary and Critical Care Medicine 2025 - LIVE STREAMING
Comprehensive Updates for State-of-the-Art Evaluation, Diagnosis, and Treatment
This comprehensive live streaming online course, which is among the highest-rated Harvard Medical School CME courses, provides education and updates to optimize your care of patients with:
• IPF
• ARDS
• Sarcoidosis
• Lung transplantation
• Bronchiectasis
• Cystic fibrosis
• Lung nodules
• Lung cancer
• Sepsis
• Pleural disease
• Pneumonia
• Tuberculosis
• Thromboembolism
... |
|
|
Enhancing Patient Care for CAR T-Cell Therapy in NHL: Comprehensive Solutions for Your Community
In this Build Your Own Case Study | Enhancing Patient Care for CAR T-Cell Therapy in NHL: Comprehensive Solutions for Your Community, learn from expert faculty about the most recent clinical updates and emerging real-world efficacy and safety data of CAR T-cell therapies in NHL. Build Your Own Case Study will guide participants through an interactive learning progression, as they go through two patient scenarios and make selections at critical decision points. Participants will be provided wit... |
|
|
Myasthenia Gravis Research Highlights: AAN 2024
This accredited CME program highlights the latest clinical research about myasthenia gravis, a rare, autoimmune disease that targets the neuromuscular junction.
Treatment of myasthenia gravis is highly individualized and depends greatly on the myasthenia gravis subtype of each patient as well as each patient’s comorbidities. There are currently five drugs approved by the FDA, eculizumab, efgartigimod, ravulizumab, rozanolixizumab, and zilucoplan. Clinical trial data on these therapies, as... |
|
|
Myasthenia Gravis Research Highlights: AAN 2024
Target Audience
This activity has been designed to meet the educational needs of physicians specializing in neurology, ophthalmology and family practice. Other members of the care team may also participate.
Program Overview
This accredited CME program highlights the latest clinical research about myasthenia gravis, a rare, autoimmune disease that targets the neuromuscular junction.
Treatment of myasthenia gravis is highly individualized and depends greatly on the myasthenia gravis subt... |
|
|
Gastroenterology 2025 - LIVE STREAMING
The Comprehensive 2025 Gastroenterology Update
This highly rated Harvard Medical School CME program ensures participants are current with state-of-the-art GI strategies and clinical practices. It covers recent advances and their impact on clinical approaches and on patient outcomes. Updates, best practices, and new guidelines are presented by nationally recognized GI experts and master clinicians.
Practical, Results-Driven Education
Highlights of the 2025 program include:
• The new... |
|
|
Multidisciplinary Team Essentials on CMV Prevention, Surveillance, and Treatment Optimization in the Transplant Setting
The role of the multidisciplinary transplant team has expanded considerably over the past decade to keep pace with advances in the field and to address long-term care of transplant recipients. Despite these advances, breakthrough cytomegalovirus (CMV) infections and development of refractory and resistant CMV infections cause significant complications post-transplant. To lessen patient burden and improve survival outcomes, optimal introduction of anti-CMV drugs, both prophylactically and thera... |
|
|
Establishing Frameworks for Precision Medicine in NTRK Fusion-Positive Advanced Solid Tumors
Despite significant advancements over the past decade, significant unmet needs persist for patients with NTRK-positive locally advanced or metastatic solid tumors. In addition, there is ongoing debate about the importance of testing for genomic alterations in rare cancers, or those that rarely occur in common cancers. However, evolving molecular testing procedures and emerging therapeutic options targeting NTRK fusions offer new pathways for the detection and treatment of these cancers. To he... |
|
|
Navigating the Evolving Standards of Newly Diagnosed Multiple Myeloma Treatment: Exploring the Evidence on New Combination Strategies
ACTIVITY DESCRIPTION
The goal of treatment for newly diagnosed multiple myeloma (NDMM) patients is achieving the deepest possible remission, which typically involves aiming for minimal residual disease negativity. Frontline therapy for NDMM is evolving to include novel induction regimens with anti-CD38 antibodies, which have been shown to yield improved depth of response after induction. These new frontline treatments vary in induction regimen composition and use of transplant, consolidation,... |
|
|
Patient Point of View: PDE4 Inhibitors for the Treatment of Adult Plaque Psoriasis
Psoriasis is a chronic, immune-mediated inflammatory skin disorder that significantly impacts affected individuals’ quality of life. The most common subtype is plaque psoriasis, characterized by erythematous to violaceous plaques covered with scales. Due to the substantial symptom burden of plaque psoriasis and challenges surrounding medication tolerability and adherence, innovative treatment options are needed. Phosphodiesterase-4 (PDE4) inhibitors, which play a key role in the inflammatory... |
|
|
HER3 in NSCLC " Navigating New Frontiers in Targeted Therapy
In patients with non-small cell lung cancer (NSCLC), human epidermal growth factor receptor 3 (HER3) is associated with both advanced disease and resistance to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)"directed therapies. Although there are therapeutic options targeting EGFR (HER1) and HER2, the potential of HER3 as an anti-cancer target has been largely overlooked. Overexpression of HER3 in most patients with NSCLC positions it as an appealing therapeutic targ... |
|
|
Therapy Tidbits – July/August 2016
Therapy Tidbits is a 1-hour online continuing education (CE) course comprised of select articles from the July/August 2016 issue of The National Psychologist, a private, independent bi-monthly newspaper intended to keep psychologists (and other mental health professionals) informed about practice issues. The articles included in this course are:
Mental Health Problems Abound in Flint Lead Crisis - discusses problems afflicting residents of Flint, MI in the city’s water contamination crisi... |
|
|
Therapy Tidbits - July/August 2017
Therapy Tidbits – July/August 2017 is a 1-hour online continuing education (CE) course comprised of select articles from the May/June 2017 issue of The National Psychologist, a private, independent bi-monthly newspaper intended to keep mental health professionals informed about practice issues. The articles included in this course are:
Telebehavioral Health is Psychology’s Future - Promotes key benefits to telebehavioral health and practical considerations that should be made before em... |
|
|
Therapy Tidbits - September/October 2017
Therapy Tidbits – September/October 2017 is a 1-hour online continuing education (CE) course comprised of select articles from the September/October 2017 issue of The National Psychologist, a private, independent bi-monthly newspaper intended to keep mental health professionals informed about practice issues. The articles included in this course are:
Practical Benefits Debatable for Geropsychology Specialty — Generalist vs specialist? This article examines which option may be a more se... |
|
|
Therapy Tidbits - May/June 2018
Therapy Tidbits - May/June 2018 is a 1-hour online continuing education (CE) course comprised of select articles from the May/June 2018 issue of The National Psychologist, a private, independent bi-monthly newspaper intended to keep mental health professionals informed about practice issues. The articles included in this course are:
New Prepayment Audits Strike Fear in Medicare Providers - Describes the difficulties practitioners are facing with when audited and explains the new m... |
|
|
Therapy Tidbits – March/April 2019
Therapy Tidbits – March/April 2019 is a 1-hour online continuing education (CE) course comprised of select articles from the March/April 2019 issue of The National Psychologist, a private, independent bi-monthly newspaper intended to keep psychologists informed about practice issues. The articles included in this course are:
Major Push Seeks to Expand RxP Jurisdictions – Discusses the efforts of the RxP movement, including challenges along the path to prescription authority for psycholo... |
|
|
Therapy Tidbits Summer 2021
Therapy Tidbits – Summer 2021 is a 1-hour online continuing education (CE) course comprised of select articles from the Summer 2021 issue of The National Psychologist, a private, independent, quarterly newspaper intended to keep psychologists informed about practice issues. The articles included in this course are:
• Improving Health through Community Policies Gains Momentum – Provides an overview of the Blue Zone Project and the impact on community members’ health.
• Psychologis... |
|
|
HIV/AIDS: Adherence Issues
HIV/AIDS: Adherence Issues is a 1-hour online continuing education (CE) course that discusses adherence issues in populations at high risk for HIV infection.
HIV and AIDS are medical terms that are linked together due to the progressive nature of HIV. When untreated or undertreated, HIV will become AIDS. The virus can affect people of all ages " children who are born to mothers who have HIV, adolescents, adults, and elders. People who are diagnosed with HIV can live almost normal lifes... |
|
|
Therapy Tidbits Spring 2022
Therapy Tidbits – Spring 2022 is a 1-hour online continuing education (CE) course comprised of select articles from the Summer 2022 issue of The National Psychologist, a private, independent, quarterly newspaper intended to keep psychologists informed about practice issues. The articles included in this course are:
No Surprises Act (NSA) Clarifies Patient Rights – Discusses the NSA and provides guidance in demonstrating good faith attempts at compliance.
Pharmacists Can be Valuable A... |
|
|
HIV/AIDS: Therapy & Adherence
HIV/AIDS: Therapy & Adherence is a 3-hour online continuing education (CE/CEU) course that reviews treatment and adherence issues in populations at high risk for HIV infection.
People who live with HIV can live almost normal lifespans and have little risk of transmitting the disease if they use antiretroviral therapy appropriately under medical care. However, only 57% of people infected with HIV follow their antiretroviral regimen well enough to achieve viral suppression.
In this co... |
|
|
Pedophilic Disorder
Pedophilic Disorder is a 2-hour online continuing education (CE) course that offers an in depth look at the defining characteristics of pedophilia and current best practices for treatment.
The diagnostic criteria for pedophilic disorder and its relationship to associated crimes, such as child molestation, human trafficking, prostitution, drug abuse, child pornography, and child abuse and neglect is discussed. Though the exact causes of pedophilia are still not well known, information is pro... |
|
|
Prescription Drug Abuse
Prescription Drug Abuse is a 3-hour online continuing education (CE) course that examines the misuse of prescription drugs (including opioids) in the United States.
Misuse of prescription drugs means “taking a medication in a manner or dose other than prescribed; taking someone else’s prescription, even if for a legitimate medical complaint such as pain; or taking a medication to feel euphoria.” The misuse of prescription drugs is a serious public health problem in the United States.
... |
|